China Cancer Drugs Market Growth


In China, cancer is a major public health concern. Several factors are responsible for the increasing prevalence of cancer in China such as extensive use of tobacco, unhealthy lifestyle and rising geriatric population. Almost one-third of the world’s lung cancer and nearly half of the liver, stomach and esophageal cases of cancer occur in China. China Cancer Drugs Market is expected to be US$ 30 Billion by the year 2024. Cancer drugs act at various levels – cancer cells, extracellular matrix, endothelium, host cells or immune system.

Read »
Created by renubresearch 2 years 16 weeks ago – Made popular 2 years 15 weeks ago
Category: Health   Tags: